Influenza

MELBOURNE, Australia — September 15, 2026 ENA Respiratory announced that the first participants have been dosed in Part B...

Delft, The Netherlands, September 10, 2026 AdJane Biosciences has announced the publication of a new white paper, “Boosting mRNA:...

Shanghai, China, August 12, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that China’s National Medical Products Administration (NMPA)...

SILVER SPRING, Md., June 17, 2026 The U.S. Food and Drug Administration (FDA) has approved the first generic version...

SHANGHAI, April 10, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. has announced a key clinical milestone with the successful dosing...